Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?Tom Nadin, Christopher J Edwards, Stefania D’Angelo et al.|BMC Musculoskeletal Disorders|2020Cited by 7
270 Tapering biological therapies: what do patients think?Claire Holmes, Christopher J Edwards, Christopher Holroyd et al.|Lara D. Veeken|2018Cited by 6
100. HIGH LEVELS OF EMPLOYMENT BUT PERSISTING WORK IMPAIRMENT IN PATIENTS WITH SEVERE AXIAL SPONDYLOARTHRITIS USING BIOLOGIC THERAPIESThomas G. Nadin, Christopher J Edwards, Dinny Wallis et al.|Lara D. Veeken|2017Cited by 1
Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?May Lwin, Christopher J Edwards, Hans de Graaf et al.|Rheumatology Advances in Practice|2020Cited by 1